148 related articles for article (PubMed ID: 9515806)
1. Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.
Nakagawa R; Motoki K; Ueno H; Iijima R; Nakamura H; Kobayashi E; Shimosaka A; Koezuka Y
Cancer Res; 1998 Mar; 58(6):1202-7. PubMed ID: 9515806
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of alpha-galactosylceramide (KRN7000) on spontaneous hepatic metastases requires endogenous interleukin 12 in the liver.
Fuji N; Ueda Y; Fujiwara H; Toh T; Yoshimura T; Yamagishi H
Clin Cancer Res; 2000 Aug; 6(8):3380-7. PubMed ID: 10955826
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production.
Nakagawa R; Motoki K; Nakamura H; Ueno H; Iijima R; Yamauchi A; Tsuyuki S; Inamoto T; Koezuka Y
Oncol Res; 1998; 10(11-12):561-8. PubMed ID: 10367937
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4 - octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice.
Motoki K; Maeda K; Ueno H; Kobayashi E; Uchida T; Fukushima H; Koezuka Y
Oncol Res; 1996; 8(4):155-62. PubMed ID: 8869965
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells.
Nakagawa R; Serizawa I; Motoki K; Sato M; Ueno H; Iijima R; Nakamura H; Shimosaka A; Koezuka Y
Oncol Res; 2000; 12(2):51-8. PubMed ID: 11132924
[TBL] [Abstract][Full Text] [Related]
7. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.
Yamaguchi Y; Motoki K; Ueno H; Maeda K; Kobayashi E; Inoue H; Fukushima H; Koezuka Y
Oncol Res; 1996; 8(10-11):399-407. PubMed ID: 9114432
[TBL] [Abstract][Full Text] [Related]
8. KRN7000, a novel immunomodulator, and its antitumor activities.
Kobayashi E; Motoki K; Uchida T; Fukushima H; Koezuka Y
Oncol Res; 1995; 7(10-11):529-34. PubMed ID: 8866665
[TBL] [Abstract][Full Text] [Related]
9. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Yamamoto M; Fujita Y; Miyagi T; Ohkawa K; Hayashi N
J Hepatol; 2008 Nov; 49(5):779-86. PubMed ID: 18760855
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
[TBL] [Abstract][Full Text] [Related]
11. FLT3-ligand administration inhibits liver metastases: role of NK cells.
PĂ©ron JM; Esche C; Subbotin VM; Maliszewski C; Lotze MT; Shurin MR
J Immunol; 1998 Dec; 161(11):6164-70. PubMed ID: 9834102
[TBL] [Abstract][Full Text] [Related]
12. Effect of KRN7000 on induced graft-vs-host disease.
Morecki S; Panigrahi S; Pizov G; Yacovlev E; Gelfand Y; Eizik O; Slavin S
Exp Hematol; 2004 Jul; 32(7):630-7. PubMed ID: 15246159
[TBL] [Abstract][Full Text] [Related]
13. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus.
Siders WM; Wright PW; Hixon JA; Alvord WG; Back TC; Wiltrout RH; Fenton RG
J Immunol; 1998 Jun; 160(11):5465-74. PubMed ID: 9605149
[TBL] [Abstract][Full Text] [Related]
14. Anti-metastatic activity of Acanthopanax senticosus extract and its possible immunological mechanism of action.
Yoon TJ; Yoo YC; Lee SW; Shin KS; Choi WH; Hwang SH; Ha ES; Jo SK; Kim SH; Park WM
J Ethnopharmacol; 2004 Aug; 93(2-3):247-53. PubMed ID: 15234760
[TBL] [Abstract][Full Text] [Related]
15. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
[TBL] [Abstract][Full Text] [Related]
16. Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock.
Sireci G; La Manna MP; Di Sano C; Di Liberto D; Porcelli SA; Kronenberg M; Dieli F; Salerno A
J Leukoc Biol; 2007 Mar; 81(3):607-22. PubMed ID: 17046969
[TBL] [Abstract][Full Text] [Related]
17. The C-glycoside analogue of the immunostimulant alpha-galactosylceramide (KRN7000): synthesis and striking enhancement of activity.
Yang G; Schmieg J; Tsuji M; Franck RW
Angew Chem Int Ed Engl; 2004 Jul; 43(29):3818-22. PubMed ID: 15258945
[No Abstract] [Full Text] [Related]
18. The administration of naked plasmid DNA into the liver induces antitumor innate immunity in a murine liver metastasis model.
Yonenaga Y; Mori A; Fujimoto A; Nagayama S; Tachibana T; Onodera H; Uemoto S
J Gene Med; 2007 Apr; 9(4):299-307. PubMed ID: 17397091
[TBL] [Abstract][Full Text] [Related]
19. AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse.
Volpe CM; Mehta N; Kim U; Hordines J; Doerr RJ; Cohen SA
J Surg Res; 1999 Jun; 84(2):157-61. PubMed ID: 10357913
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer.
Ishikawa A; Motohashi S; Ishikawa E; Fuchida H; Higashino K; Otsuji M; Iizasa T; Nakayama T; Taniguchi M; Fujisawa T
Clin Cancer Res; 2005 Mar; 11(5):1910-7. PubMed ID: 15756017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]